David B Stewart1, Emmanuel Yacoub, Junjia Zhu. 1. Department of Surgery, Division of Colorectal Surgery, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA. dstewart@hmc.psu.edu
Abstract
BACKGROUND: Clostridium difficile colitis (CDC) patients receiving chemotherapy for hematologic malignancies are anticipated to have worse outcomes than immunocompetent CDC patients. STUDY DESIGN: An IRB approved retrospective cohort study (2004-2009) identified an equal number (n = 49) of CDC inpatients receiving chemotherapy for hematologic malignancies (CDC-HM) as well as CDC patients without malignancies (CDC-NM). Chi-squared tests, linear regression, and analysis of variance were used to compare outcomes. RESULTS: No difference (p > 0.05) was noted between groups regarding age, hypertension, diabetes, COPD, or coronary artery disease. Approximately 62 % of CDC-HM patients required colony-stimulating factor for neutropenia. There was no difference (p > 0.05) in peak lactate or creatinine levels. None of the CDC-HM group required colectomy, while four CDC-NM patients required surgery (p = 0.04); neither group experienced death. No differences were noted regarding need for ICU admission for CDC or the need for vasopressors (p > 0.05). Mean hospital length of stay was longer for the CDC-HM group (22 days vs. 10 days; p = 0.001). CONCLUSIONS: CDC-HM patients had longer lengths of stay than CDC-NM patients without an increase in rates of death, colectomy, or ICU admission. Outcomes in CDC-HM are better than many would anticipate, underscoring the current knowledge deficit regarding C. difficile infection.
BACKGROUND:Clostridium difficilecolitis (CDC) patients receiving chemotherapy for hematologic malignancies are anticipated to have worse outcomes than immunocompetent CDC patients. STUDY DESIGN: An IRB approved retrospective cohort study (2004-2009) identified an equal number (n = 49) of CDC inpatients receiving chemotherapy for hematologic malignancies (CDC-HM) as well as CDC patients without malignancies (CDC-NM). Chi-squared tests, linear regression, and analysis of variance were used to compare outcomes. RESULTS: No difference (p > 0.05) was noted between groups regarding age, hypertension, diabetes, COPD, or coronary artery disease. Approximately 62 % of CDC-HM patients required colony-stimulating factor for neutropenia. There was no difference (p > 0.05) in peak lactate or creatinine levels. None of the CDC-HM group required colectomy, while four CDC-NM patients required surgery (p = 0.04); neither group experienced death. No differences were noted regarding need for ICU admission for CDC or the need for vasopressors (p > 0.05). Mean hospital length of stay was longer for the CDC-HM group (22 days vs. 10 days; p = 0.001). CONCLUSIONS: CDC-HM patients had longer lengths of stay than CDC-NM patients without an increase in rates of death, colectomy, or ICU admission. Outcomes in CDC-HM are better than many would anticipate, underscoring the current knowledge deficit regarding C. difficileinfection.
Authors: Gerly A C Brito; Gail W Sullivan; William P Ciesla; Holliday T Carper; Gerald L Mandell; Richard L Guerrant Journal: J Infect Dis Date: 2002-04-16 Impact factor: 5.226
Authors: J I Arango; A Restrepo; D L Schneider; N S Callander; J L Ochoa-Bayona; M I Restrepo; P Bradshaw; J Patterson; C O Freytes Journal: Bone Marrow Transplant Date: 2006-03 Impact factor: 5.483
Authors: K Hornbuckle; A Chak; H M Lazarus; G S Cooper; L A Kutteh; R Gucalp; P S Carlisle; J Sparano; P Parker; R A Salata Journal: Ann Oncol Date: 1998-03 Impact factor: 32.976
Authors: Graeme S Cottrell; Silvia Amadesi; Stella Pikios; Eric Camerer; J Adam Willardsen; Brett R Murphy; George H Caughey; Paul J Wolters; Shaun R Coughlin; Anders Peterson; Wolfgang Knecht; Charalabos Pothoulakis; Nigel W Bunnett; Eileen F Grady Journal: Gastroenterology Date: 2007-04-13 Impact factor: 22.682
Authors: Erik R Dubberke; Kimberlay A Reske; Anand Srivastava; Justin Sadhu; Robert Gatti; Rebecca M Young; Lauren C Rakes; Brian Dieckgraefe; John DiPersio; Victoria J Fraser Journal: Clin Transplant Date: 2009-07-13 Impact factor: 2.863
Authors: Young Kyung Yoon; Min Ja Kim; Jang Wook Sohn; Hye Suk Kim; Yoon Ji Choi; Jung Sun Kim; Seung Tae Kim; Kyong Hwa Park; Seok Jin Kim; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Yong Park Journal: Support Care Cancer Date: 2014-03-05 Impact factor: 3.603
Authors: Analia Rodríguez Garzotto; Antonio Mérida García; Nerea Muñoz Unceta; M Mar Galera Lopez; M Ángeles Orellana-Miguel; C Vanesa Díaz-García; Susana Cortijo-Cascajares; Hernán Cortes-Funes; M Teresa Agulló-Ortuño Journal: Support Care Cancer Date: 2014-11-20 Impact factor: 3.603